Cellular Biomedical Group increases knee cartilage in some Chinese patients

CHINA TESTS REPORT CARTILAGE REGROWTH (Orthopedics This Week)
A clinical trial of human adipose-derived mesenchymal cell (haMPC) therapy for knee osteoarthritis (KOA) has shown positive results with some patient cartilage showing regrowth within three months. Cellular Biomedical Group, Inc. of Palo Alta, California (CBMG) is reporting on the Phase I/II clinical trials at Shanghai Renji Hospital, China.
According to the company, the primary endpoints of the studies were safety and knee-related pain, stiffness and function. Secondary endpoints were cartilage repair at six months, defined by the ...